Replies to post #60461 on Biotech Values

[DewDiligence]

>MNTA – He specifically mentioned Enoxaparin in-vitro assays forming the basis of a supplemental data package.<

He did, indeed. Fier sounded more definitive about it than Wheeler did on the 4Q07 CC one month ago.